These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34265566)
1. Simultaneous measurements of single gamma ray of Ogane K; Uenomachi M; Shimazoe K; Takahashi M; Takahashi H; Seto Y; Momose T Appl Radiat Isot; 2021 Oct; 176():109864. PubMed ID: 34265566 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous in vivo imaging with PET and SPECT tracers using a Compton-PET hybrid camera. Uenomachi M; Takahashi M; Shimazoe K; Takahashi H; Kamada K; Orita T; Ogane K; Tsuji AB Sci Rep; 2021 Sep; 11(1):17933. PubMed ID: 34504184 [TBL] [Abstract][Full Text] [Related]
3. Compton-camera-based SPECT for thyroid cancer imaging. Yu H; Wang G J Xray Sci Technol; 2021; 29(1):111-124. PubMed ID: 33325449 [TBL] [Abstract][Full Text] [Related]
4. Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study. Kist JW; de Keizer B; Stokkel MP; Hoekstra OS; Vogel WV; BMC Cancer; 2014 Jun; 14():405. PubMed ID: 24906384 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL; Xue YL; Song HJ; Luo QY Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353 [TBL] [Abstract][Full Text] [Related]
6. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792 [TBL] [Abstract][Full Text] [Related]
18. Imaging of Nakano T; Sakai M; Torikai K; Suzuki Y; Takeda S; Noda SE; Yamaguchi M; Nagao Y; Kikuchi M; Odaka H; Kamiya T; Kawachi N; Watanabe S; Arakawa K; Takahashi T Phys Med Biol; 2020 Feb; 65(5):05LT01. PubMed ID: 31323647 [TBL] [Abstract][Full Text] [Related]
19. Complementary role of 18F-fluorodeoxyglucose positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer. Hsu CH; Liu RS; Wu CH; Chen SM; Shih LS J Formos Med Assoc; 2002 Jul; 101(7):459-67. PubMed ID: 12353337 [TBL] [Abstract][Full Text] [Related]
20. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases. Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]